Literature DB >> 28281164

Abdominal Visceral to Subcutaneous Adipose Tissue Ratio Is Associated with Increased Risk of Erosive Esophagitis.

Eun Young Ze1, Beom Jin Kim2, Hyun Kang3, Jae Gyu Kim1.   

Abstract

BACKGROUND: To investigate the association between abdominal fat distribution represented by the visceral fat area (VFA) to subcutaneous fat area (SFA) ratio, and erosive esophagitis (EE).
METHODS: Seven hundred and twenty-eight participants aged >40 years underwent physical examination, blood tests, esophagogastroduodenoscopy, and abdominal computer tomography at Chung-Ang University Hospital from 2007 to 2012.
RESULTS: Of 728 subjects, 65 (8.9%) had EE. The EE patients had higher body mass index, metabolic syndrome prevalence, triglyceride levels, and blood pressure (P < 0.05). The mean VFA/SFA ratio was higher in the EE group than in the non-EE group (1.30 vs. 0.92, P < 0.001). The predominance of EE in the group with higher VFA/SFA ratio was higher than in the group with lower VFA/SFA ratio (P < 0.001). A VFA/SFA ratio ≥1.165 had good accuracy to predict EE (area under the receiver-operating characteristic curve, 0.643). The VFA/SFA ratio and visceral fat volume were positively correlated with the severity of EE (P = 0.002), and a VFA/SFA ratio ≥1.165 was strongly correlated with the severity of EE (P < 0.001).
CONCLUSION: The high VFA/SFA ratio can be a useful clinical predictor of EE.

Entities:  

Keywords:  Erosive esophagitis; Gastroesophageal reflux disease; Subcutaneous fat area; Visceral fat area

Mesh:

Year:  2017        PMID: 28281164      PMCID: PMC5397435          DOI: 10.1007/s10620-017-4467-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


Introduction

Gastroesophageal reflux disease (GERD) is a common disorder. The approximate prevalence of GERD in the Western world is 10–20% [1]. Mucosal damage produced by the abnormal reflux of gastric contents into the esophagus is observed in some cases of GERD [2]. Male gender, hiatal hernia, Helicobacter pylori infection, smoking, and alcohol consumption can increase the risk of erosive esophagitis (EE) [3, 4]. In addition, common features of metabolic syndrome are risk factors for EE [5, 6]. Obesity, a central component of metabolic syndrome, is known to promote gastroesophageal reflux. Of note, the increase in intra-abdominal pressure due to obesity contributes to EE. Some studies have suggested that the risk of GERD or EE increases with increasing body mass index (BMI) [7-9]. Most studies have used BMI as an indicator of obesity. However, BMI is an imperfect estimate of adiposity, particularly in men, owing to the greater muscle mass in this group [10]. Moreover, the association between increased BMI and EE is inconsistent and varies with sex, ethnic origin, and other confounding factors [11-13]. Therefore, the pattern of obesity may be a better predictor of GERD than BMI [14]. Several studies have suggested that abdominal obesity can be a risk factor for GERD [15]. A previous study indicated that GERD symptoms were positively associated with the abdominal diameter in Caucasian men independently of BMI [16]. Moreover, abdominal adipose tissue consists of subcutaneous fat (SF) and visceral fat (VF), and recent studies revealed the association between abdominal VF and EE [17, 18]. A recent study reported that abdominal VF volume measured by cross-sectional computerized tomography (CT) is a more important risk factor for EE than other factors such as BMI and abdominal circumference in both sexes [17]. However, because of individual differences in the absolute amount of VF, this parameter may not indicate obesity directly; therefore, the relative ratio of VF to SF may indicate obesity more accurately. We hypothesized that the ratio of visceral fat area (VFA) to subcutaneous fat area (SFA), measured by CT, rather than BMI, might significantly correlate with the risk of EE. Therefore, the aim of this study was to investigate the association between abdominal fat distribution, represented by the VFA/SFA ratio, and the incidence of EE in the general population.

Methods

Study Population

Subjects older than 40 years were enrolled in a routine checkup program at the Health Care Center of Chung-Ang University Hospital from January 2007 to December 2012. A total of 728 participants underwent a physical examination (height, body weight, waist circumference, and blood pressure), blood tests [glucose, triglycerides (TG), and high-density lipoprotein (HDL) cholesterol], esophagogastroduodenoscopy (EGD), and abdominal CT scan. The Institutional Review Board approved the study [Protocol No. C2013001(961)], and all the participants provided a written informed consent.

Measurement of Anthropometric Parameters

Height and body weight measurements were automated (GL-150; G-Tech international Co., Uijungbu City, Korea, Inbody 720; Biospace Co., Chun-An City, Korea), and BMI was calculated as weight divided by height squared (kg/m2) [19]. Waist circumference was measured by trained nurses at the midpoint between the lower borders of the rib cage and upper pole of the iliac crest. After fasting for 12 h, blood samples were taken for measurement of blood lipids and glucose. Metabolic syndrome was defined on the basis of the criteria established by the National Cholesterol Education Program (NCEP). The NCEP criteria for metabolic syndrome require that at least three of the following conditions be met: waist circumference >40 in. in men and >35 in. in women, plasma TG >150 mg/dl, HDL cholesterol <40 mg/dl in men and <50 mg/dl in women, blood pressure ≥130/85 mmHg, and fasting plasma glucose ≥110 mg/dl [20].

Endoscopy

EGD was performed using a flexible endoscope (CV-260SL; Olympus, Tokyo, Japan) after overnight fasting. We inspected the gastroesophageal junction at the start of the endoscopic examination before inflation of the stomach or at the end of the examination after deflation of the stomach. The severity of EE was graded from A to D according to the Los Angeles (LA) classification system [21]. Hiatal hernia was considered present if the gastroesophageal junction extended at least 2 cm above the diaphragmatic hiatus impression during quiet respiration [22].

Measurement of Abdominal Adipose Tissue Area by CT

The abdominal adipose tissue area was quantified using 64-multidetector CT (Brilliance; Philips medical systems, Cleveland, OH, USA). The fat area was determined by measuring the mean value of the pixels within the range between −175 and −25 Hounsfield units. The total abdominal fat area (TFA), VFA, and SFA were measured by the acquisition of a 10-cm CT slice scan image of the third and fourth lumbar vertebrae during suspended respiration. The area (cm2) was calculated using Extended Brilliance Workspace software (version 1-4.5.2, Philips Healthcare, Best, Netherland). VFA was calculated by delineating the intra-abdominal cavity bound by the parietal peritoneum or transversalis fascia, and excluding the vertebral column and paraspinal muscles. SFA was calculated by subtracting VFA from TFA.

Statistical Analysis

Categorical variables were evaluated using χ 2 test or Fisher’s exact test. Continuous variables were evaluated using Student’s t test. Continuous variables were expressed as mean ± SD. A p value of <0.05 was considered statistically significant. The software package SPSS version 20.0 was used for analysis (SPSS Inc., Chicago, IL, USA).

Results

Baseline Demographic and Clinical Characteristics of the Subjects

A total of 728 subjects were included in this study. The mean age of the patients was 47.15 years; 629 (86.4%) patients were male, and 99 (13.6%) were female. The mean BMI was 24.66 kg/m2, and 65 (8.9%) patients had metabolic syndrome. On EGD, 65 (8.9%) patients had EE, and 11 (1.5%) patients had hiatal hernias. On CT, the mean VFA, SFA, and VFA/SFA ratio were 2886.97, 3627.27, and 1.02 cm2, respectively (Table 1).
Table 1

Baseline demographic and clinical characteristics

Variables
Number of subjects728
Age (mean ± SD, years)47.15 ± 8.35
Sex
 Male629 (86.4)
 Female99 (13.6)
BMI (kg/m2) (mean ± SD)24.66 ± 2.85
Metabolic syndrome
 Yes65 (8.9)
 No663 (91.1)
Blood pressure (mean ± SD, mmHg)124.30 ± 14.72
HDL cholesterol (mg/dl)49.09 ± 9.21
Triglyceride (mg/dl)41.78 ± 36.08
Fasting glucose (mg/dl)101.02 ± 19.39
Erosive esophagitis
 Yes65 (8.9)
 No663 (91.1)
Hiatal hernia
 Yes11 (1.5)
 No717 (98.5)
VF area (cm2)2886.97 ± 5260.61
SF area (cm2)3627.27 ± 7764.85
VF/SF ratio (mean ± SD)1.02 ± 0.49

BMI body mass index; high blood pressure, ≥130/85 mmHg or documented use of antihypertensive therapy, LDL low-density lipoprotein, HDL high-density lipoprotein, SF subcutaneous fat, VF visceral fat

Baseline demographic and clinical characteristics BMI body mass index; high blood pressure, ≥130/85 mmHg or documented use of antihypertensive therapy, LDL low-density lipoprotein, HDL high-density lipoprotein, SF subcutaneous fat, VF visceral fat

Clinical Characteristics of Subjects With and Without EE

Among the 728 subjects, 65 (8.9%) patients had EE. The patients with EE were predominantly female (Table 2). The mean BMI was higher in the EE group than in the non-EE group (25.80 vs. 24.40, P = 0.002). Metabolic syndrome was more prevalent in the EE group than in the non-EE group (30.8 vs. 13.7%, P < 0.001). Moreover, TG and blood pressure levels were higher in patients with EE. On EGD, hiatal hernia was more prevalent in the EE group than in the non-EE group (9.2 vs. 0.8%, P < 0.001). However, VFA was not significantly different between the two groups (1595.00 vs. 1426.00 cm2, P = 0.927). Conversely, SFA was higher in the non-EE group than in the EE group (1226.92 vs. 1514.46 cm2, P = 0.010). Moreover, the mean VFS/SFA ratio was higher in the EE group than in the non-EE group (1.30 vs. 0.92, P < 0.001).
Table 2

Comparison of clinical characteristics between subjects with reflux esophagitis and those without

Subjects with reflux esophagitis (n = 65)Subjects without reflux esophagitis (n = 663) P value
Age (range, years)46 (42–50)48 (42–53)0.260
Sex0.003
 Male (%)1 (1.5)98 (14.8)
 Female (%)64 (98.5)565 (85.2)
BMI (kg/m2)25.80 (23.55–27.65)24.40 (22.70–26.20)0.002
Metabolic syndrome<0.001
 Yes (%)20 (30.8)91 (13.7)
 No (%)45 (69.2)572 (86.3)
HDL cholesterol (mg/dl)46 (40–52)48 (43–54)0.066
Triglyceride (mg/dl)45 (26–65)29 (20–49)<0.001
High blood pressure0.006
 Yes (%)35 (53.8)242 (36.6)
 No (%)30 (46.2)420 (63.4)
Fasting glucose (mg/dl)98.00 (93.50–107.00)97.00 (91.00–105.00)0.307
Hiatal hernia6 (9.2)5 (0.8)<0.001
VF area (cm2)1595.00 (841.50–1936.50)1426.00 (998.00–1950.00)0.927
SF area (cm2)1226.92 (707.58–2054.67)1514.46 (945.68–2772.09)0.010
VF/SF1.30 (0.87–1.63)0.92 (0.67–1.29)<0.001

BMI body mass index; high blood pressure, ≥130/85 mmHg or documented use of antihypertensive therapy, LDL low-density lipoprotein, HDL high-density lipoprotein, NS nonspecific, SF subcutaneous fat, VF visceral fat

Comparison of clinical characteristics between subjects with reflux esophagitis and those without BMI body mass index; high blood pressure, ≥130/85 mmHg or documented use of antihypertensive therapy, LDL low-density lipoprotein, HDL high-density lipoprotein, NS nonspecific, SF subcutaneous fat, VF visceral fat

Risk Factors for EE

The results of the multivariate logistic regression analysis demonstrated that hiatal hernia (P < 0.001), VFA/SFA ratio ≥1.165 (P = 0.010), and high TG level (P = 0.015) were independent risk factors for EE. Hiatal hernia was strongly associated with an increased risk of EE [adjusted odds ratio (OR), 12.90; 95% confidence interval (CI), 3.57–46.65]. Similarly, a VFA/SFA ratio ≥1.165 was a significant risk factor for EE (OR 2.04; 95% CI 1.18–3.51; Table 3).
Table 3

Logistic regression analysis of covariables for erosive esophagitis

VariableOR (95% CI)Univariate analysis (p)OR (95% CI)Multivariate analysis (p)
Age (years)
 <65 (n = 714)1
 ≥65 (n = 14)1.88 (0.41–8.68)0.326
Sex
 Female (n = 99)1
 Male (n = 629)0.09 (0.01–0.66)0.0030.19 (0.03–1.40)0.191
BMI (kg/m2)
 <25 (n = 665)1
 ≥25 (n = 63)2.25 (1.33–3.81)0.0021.64 (0.93–2.87)0.086
Metabolic syndrome
 No (n = 663)1
 Yes (n = 65)2.79 (1.58–4.95)<0.0010.82 (0.33–2.01)0.819
HDL cholesterol (mg/dl)
 <40 (n = 631)1
 ≥40 (n = 97)1.37 (0.69–2.72)0.371
Triglyceride (mg/dl)
 <150 (n = 714)1
 ≥150 (n = 14)6.06 (1.97–18.65)0.0054.74 (1.35–16.62)0.015
High blood pressure
 No (n = 452)1
 Yes (n = 276)2.04 (1.22–3.41)0.0061.72 (0.97–3.07)0.065
Fasting glucose (mg/dl)
 <110 (n = 609)1
 ≥110 (n = 119)0.93 (0.46–1.87)0.826
Hiatal hernia
 No (n = 717)1
 Yes (n = 11)13.38 (3.97–45.17)0.00112.90 (3.57–46.65)<0.001
VF/SF ratio
 <1.165 (n = 477)1
 ≥1.165 (n = 251)2.77 (1.65–4.65)<0.0012.04 (1.18–3.51)0.010

BMI body mass index, CI confidence interval; high blood pressure, ≥130/85 mmHg or documented use of antihypertensive therapy, LDL low-density lipoprotein, HDL high-density lipoprotein, VF visceral fat, SF subcutaneous fat

Logistic regression analysis of covariables for erosive esophagitis BMI body mass index, CI confidence interval; high blood pressure, ≥130/85 mmHg or documented use of antihypertensive therapy, LDL low-density lipoprotein, HDL high-density lipoprotein, VF visceral fat, SF subcutaneous fat

Association Between EE and VFA/SFA Ratio

The analysis of the correlation between EE and the VFA/SFA ratio indicated that the incidence of EE was higher in the group with the higher VFA/SFA ratio (P < 0.001; Fig. 1). In addition, the receiver-operating characteristic (ROC) curve indicated that a VFA/SFA ratio ≥1.165 had good accuracy to predict EE (area under the ROC curve = 0.643; Fig. 2).
Fig. 1

Association between erosive esophagitis and VF/SF ratio. The incidence of erosive esophagitis was higher in the group with the higher VFA/SFA ratio (P for trend <0.001)

Fig. 2

AUROC of VF/SF ratio in the identification of erosive esophagitis. Receiver-operating characteristic (ROC) curve indicated that a VFA/SFA ratio ≥1.165 had a good accuracy to predict erosive esophagitis (AUROC = 0.643). AUROC area under the receiver operator characteristic curve

Association between erosive esophagitis and VF/SF ratio. The incidence of erosive esophagitis was higher in the group with the higher VFA/SFA ratio (P for trend <0.001) AUROC of VF/SF ratio in the identification of erosive esophagitis. Receiver-operating characteristic (ROC) curve indicated that a VFA/SFA ratio ≥1.165 had a good accuracy to predict erosive esophagitis (AUROC = 0.643). AUROC area under the receiver operator characteristic curve

Effect of VFA/SFA Ratio on the Severity of EE

The severity of EE was positively correlated with the VFA/SFA ratio and VF volume (P = 0.002; Table 4). The risk of EE types LA-A, LA-B, and LA-C/LAC-D increased 1.23-fold, 1.27-fold, and 1.56-fold, respectively. Of note, a VFA/SFA ratio ≥1.165 was strongly correlated with the severity of EE (P < 0.001; Table 5).
Table 4

Association between visceral fat/subcutaneous fat ratio and severity of erosive esophagitis

NormalLA-ALA-BLA-C, D
No. of subjects (%)663 (91.1)50 (6.9)14 (1.9)1 (0.1)
VF/SF (mean ± SD)1.00 ± 0.491.23 ± 0.531.27 ± 0.471.56
P value0.002

VF visceral fat, SF subcutaneous fat

Table 5

Severity of erosive esophagitis according to visceral fat/subcutaneous fat ratio

NormalLA-ALA-BLA-C, D
No. of subjects (%)663 (91.1)50 (6.9)14 (1.9)1 (0.1)
VF/SF <1.165449 (94.1)24 (5.0)4 (0.9)0 (0.0)
VF/SF ≥1.165214 (85.3)26 (10.3)10 (4.0)1 (0.4)
P for trend<0.001
P value<0.001

VF visceral fat, SF subcutaneous fat

Association between visceral fat/subcutaneous fat ratio and severity of erosive esophagitis VF visceral fat, SF subcutaneous fat Severity of erosive esophagitis according to visceral fat/subcutaneous fat ratio VF visceral fat, SF subcutaneous fat

Discussion

Our study identified a positive correlation between EE and each of the following individual factors: high BMI, metabolic syndrome, high VFA/SFA ratio, hiatal hernia, high TG level, high blood pressure, and female sex. However, multivariate analysis revealed that only high VFA/SFA ratio, hiatal hernia, and high TG level were associated with EE. In a previous study, multivariate logistic regression analysis revealed that VFA was associated with EE [18]. Previous studies demonstrated that women have lower VF and higher SF than men [17, 23]. In our study, however, VFA did not show a significant association with EE, as a higher proportion of women might have resulted in a lower VFA than expected in the EE group. In other studies, multivariate analysis found that high BMI, waist circumference, and waist-to-hip ratio were associated with EE [17, 18]. Although these parameters are easily obtainable, these are imperfect measures of adiposity owing to confounding factors such as sex and ethnic origin. While in some Asian populations the prevalence of obesity is lower than that in western countries, health risks associated with obesity occur at a lower BMI in Asian populations, and these populations are predisposed to abdominal obesity [24]. Several hypotheses have been formulated to explain how obesity can cause GERD [25-27]. Previous studies have indicated that obesity can lead to EE via dietary, mechanical, and humoral factors [15, 26]. A previous study has shown that the amount and type of dietary intake are responsible for GERD [28]. Moreover, an increase in abdominal adipose tissue leads to increased intra-abdominal and intragastric pressure, increased rate of transit, lower esophageal sphincter relaxation, formation of hiatal hernia, and subsequent esophageal acid reflux [25]. Humoral and hormonal factors are also involved in the correlation between obesity and GERD. A large cohort study found that compared to men with obesity, women with obesity had a greater risk of GERD symptoms, with the risk being highest in premenopausal women and postmenopausal women undergoing estrogen therapy [29]. Furthermore, VF is strongly associated with elevated serum levels of several proinflammatory cytokines, including interleukin-6 and tumor necrosis factor-alpha, which are overexpressed in patients with EE [30, 31]. Several studies have evaluated obesity by measuring BMI and waist circumference. BMI is associated with increased transient lower esophageal sphincter relaxation [32]. Waist circumference and BMI are significantly correlated with intragastric pressure, gastroesophageal pressure gradient, and separation of the gastroesophageal junction pressure components [33, 34]. However, the association between BMI and GERD is affected by many confounding factors [7, 12, 13, 16]. Moreover, anthropometric measurements are less accurate and less reproducible in obesity studies. Abdominal visceral adipose tissue, which is associated with increased intra-abdominal pressure, may be a better predictor of GERD than other obesity parameters. The most important mechanism involved in the correlation between obesity with GERD is intra-abdominal pressure, which plays a significant role in acid reflux [35]. Moreover, abdominal CT is more accurate and more reproducible than anthropometry because CT allows for the direct assessment of SF and VF compartments, whereas anthropometric measurements do not. VFA is an indicator of abdominal fat and a strong predictor of insulin resistance and coronary artery disease [33, 36]. However, the high cost and radiation exposure should be considered. In our study, the VFA/SFA ratio was a more significant risk factor for EE than BMI, waist circumference, waist-to-hip ratio, and VFA. Moreover, we found that a VFA/SFA ratio ≥1.165 might be a useful indicator for predicting EE. In addition, the severity of EE was positively correlated with the VFA/SFA ratio. Our study has several strengths. First, the methods used allowed for the acquisition of high-quality data. Furthermore, EE was objectively evaluated via EGD and categorized using the Los Angeles classification, and minor changes were excluded to increase specificity. Second, abdominal adipose tissue was measured using 64-multidetector CT, which has a high degree of validity and reproducibility [23]. Furthermore, we suggested cutoff values for normal versus abnormal VFA/SFA ratios. Our study also has the following limitations. First, the study population was based on subjective screening; therefore, there could have been a selection bias. Second, we did not evaluate individual diet or lifestyle factors such as alcohol consumption and smoking status.

Conclusion

The VFA/SFA ratio was positively associated with EE. The pattern of obesity was more important than BMI, and the VFA/SFA ratio was used in the diagnosis of VF-type abdominal obesity. We suggest that a high VFA/SFA ratio is a useful clinical predictor of EE. Therefore, individuals with a high VFA/SFA ratio may need endoscopic evaluation for EE. Further studies are needed to determine the treatment success of EE based on the VFA/SFA ratios.
  36 in total

Review 1.  Guidelines for healthy weight.

Authors:  W C Willett; W H Dietz; G A Colditz
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

2.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

3.  Body-mass index and symptoms of gastroesophageal reflux in women.

Authors:  Brian C Jacobson; Samuel C Somers; Charles S Fuchs; Ciarán P Kelly; Carlos A Camargo
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

4.  Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey.

Authors:  C E Ruhl; J E Everhart
Journal:  Ann Epidemiol       Date:  1999-10       Impact factor: 3.797

5.  Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.

Authors:  Hashem B El-Serag; David Y Graham; Jessie A Satia; Linda Rabeneck
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

6.  Visceral fat accumulation as a risk factor for prostate cancer.

Authors:  Pedro von Hafe; Francisco Pina; Ana Pérez; Margarida Tavares; Henrique Barros
Journal:  Obes Res       Date:  2004-12

Review 7.  Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis.

Authors:  Douglas A Corley; Ai Kubo
Journal:  Am J Gastroenterol       Date:  2006-09-04       Impact factor: 10.864

8.  Association of obesity with hiatal hernia and esophagitis.

Authors:  L J Wilson; W Ma; B I Hirschowitz
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

9.  Obesity is associated with increased transient lower esophageal sphincter relaxation.

Authors:  Justin Che-Yuen Wu; Lik-Man Mui; Carrian Man-Yuen Cheung; Yawen Chan; Joseph Jao-Yiu Sung
Journal:  Gastroenterology       Date:  2006-12-19       Impact factor: 22.682

10.  Association between reflux oesophagitis and features of the metabolic syndrome in Japan.

Authors:  F Moki; M Kusano; M Mizuide; Y Shimoyama; O Kawamura; H Takagi; T Imai; M Mori
Journal:  Aliment Pharmacol Ther       Date:  2007-10-01       Impact factor: 8.171

View more
  5 in total

1.  Objective ambulatory pH monitoring and subjective symptom assessment of gastroesophageal reflux disease show type of carbohydrate and type of fat matter.

Authors:  Cihang Gu; Timothy Olszewski; Michael F Vaezi; Kevin D Niswender; Heidi J Silver
Journal:  Therap Adv Gastroenterol       Date:  2022-05-31       Impact factor: 4.802

2.  Relationship between obesity and development of erosive reflux disease: A mediation analysis of the role of cardiometabolic risk factors.

Authors:  Hyuk Lee; Yaeji Lim; Sangah Chi; Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Poong-Lyul Rhee; Jae J Kim
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

3.  The Influences of Visceral Fat Area on the Sites of Esophageal Mucosal Breaks in Subjects with Gastroesophageal Reflux Diseases.

Authors:  Ji Hyung Nam; Eirie Cho; Jeung Sook Kim; Eun-Cheol Park; Jae Hak Kim
Journal:  Gastroenterol Res Pract       Date:  2019-02-17       Impact factor: 2.260

4.  Association between the body mass index, waist circumference, and body fat percentage with erosive esophagitis in adults with obesity after sleeve gastrectomy.

Authors:  Alba S Zevallos-Ventura; Gabriel de la Cruz-Ku; Fernando M Runzer-Colmenares; Jesús Pinto-Elera; Carlos J Toro-Huamanchumo
Journal:  F1000Res       Date:  2022-02-22

Review 5.  Role of Overweight and Obesity in Gastrointestinal Disease.

Authors:  Sara Emerenziani; Michele Pier Luca Guarino; Laura Maria Trillo Asensio; Annamaria Altomare; Mentore Ribolsi; Paola Balestrieri; Michele Cicala
Journal:  Nutrients       Date:  2019-12-31       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.